Report of a rare case in Thailand: dengue hemorrhagic fever in a female patient with glucose-6-phosphate dehydrogenase (G6PD) deficiency


  • Waraporn Somwong คณะเวชศาสตร์เขตร้อน มหาวิทยาลัยมหิดล
  • Panjit Phothong Nurse, Department of Nursing, Hospital for Tropical Diseases, Mahidol University
  • Kongkeaw Younboonhlim Nurse, Department of Nursing, Hospital for Tropical Diseases, Mahidol University
  • Akemanee Pattanapipitpaisarn 1Medical Technologist, Diagnostic Laboratory, Mahidol University


dengue hemorrhagic fever, G6PD deficiency


Glucose-6-phosphate dehydrogenase deficiency is an X-linked recessive disorder, involving decreasing activity of enzyme induced hemolysis. This condition manifests in males more often than females. Therefore, a rare case study is presented as described below.

A 22-year-old female from Bangkok was admitted to the Hospital for Tropical Diseases. She presented fever, chills, headache, anorexia and minimal amount of menstruation (the 3rd day of cycle). Laboratory investigation revealed positive for dengue NS-1 antigen, positive for IgM and IgG antibody, WBC count 2,600 cells/mm3 with atypical lymphocytes 9% and platelet count 17,000 cells/mm3. The doctor diagnosed dengue hemorrhagic fever and found urobilinogen 3+ in urine. G6PD activity showed low G6PD level. This condition can cause hemolysis in dengue infection.


Download data is not yet available.



Tanphaichitr VS, Chonlasin R, Suwantol L, Pung-Amritt P, Tachavanich K, Yogsan S, et al. Effect of red blood cell glucose-6-phosphate

dehydrogenase deficiency on patients with dengue hemorrhagic fever. J Med Assoc Thai. 2002;85(Suppl 2):S522-9.

Natesirinilkul R, Tantiworawit A, Charoenkwan P. Clinical course of dengue in patients with thalassaemia Paediatr Int Child Health. 2013;33:32-6.

Beutler E. Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood. 2008;111:16-24.

Francis RO, Jhang JS, Pham HP, Hod EA, Zimring JC Spitalnik SL. Glucose-6-phosphate dehydrogenase deficiency in transfusion medicine; the unknown risks. Vox Sang. 2013;105:271-82.

Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009;42:267-78.

Kitti Torcharus. Glucose-6-phosphate dehydrogenase deficiency (G-6-PD). The Thai Society of Hematology [Internet]. 2021. [cited 2021 Aug 10]. Available from:

Hecker PA, Lionetti V, Ribeiro RF, Jr., Rastogi S, Brown BH, O’Connell KA, et al. Glucose-6-phosphate dehydrogenase deficiency increases redox stress and moderately Accelerates the development of heart failure. Circ Heart Fail. 2013;6:118-26.

Luzzatto L, Seneca E. G6PD deficiency: a classic example of pharmacogenetics with on going clinical implications. Br J Heamatol. 2014;164:469-80.

WHO Working Group. Glucose-6-phospate dehydrogenase deficiency. Bull World Health Organ. 1989;67:601-11.

Al-alimi AA, A.Ali S, Al-Hassan F, et al. Dengue virus type 2 (DENV2)- induced oxidative responses in monocytes from Glucose-6-phosphate dehydrogenase (G6PD)-deficient and G6PD normal subjects. PLOS Neglected Tropical diseases. 2014;8:1-9.





รายงานผู้ป่วย (Case report)